Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Osteosarcoma is a cancer of the bone that is most common in adolescents. Osteosarcoma usually starts in osteoblasts, which are a type of bone cell that becomes new bone tissue and usually forms in the ends of the long bones of the body, which include bones of the arms and legs. It affects more males than females.
Malignant fibrous histiocytoma (MFH) of bone is a rare tumor of the bone. It is treated like osteosarcoma.
Learn about osteosarcoma and find information on how we support and care for people with osteosarcoma before, during, and after treatment.
The following information is from the National Cancer Institute (NCI).
Clinical Trials Questions?
New Patient Appointments
As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.
We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.
See patient satisfaction survey results for different Dana-Farber locations collected by Press Ganey, an independent company experienced in patient satisfaction surveying.